Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 3,565.00
-45.00 (-1.25%)
Oct 23, 2026, 3:30 PM JST
Towa Pharmaceutical Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Towa Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥5,350. The average 1-year stock price forecast is 50.07% higher than the current stock price, while the lowest is ¥4,200 (+17.81%) and the highest is ¥6,300 (+76.72%).
Price Target: ¥5,350 (+50.07%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 12, 2026.
Analyst Ratings
The average analyst rating for Towa Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Upgrades ¥4,500 → ¥5,600 | Buy | Upgrades | ¥4,500 → ¥5,600 | +57.08% | Jun 12, 2026 |
Financial Forecast
Revenue This Year
306.59B
from 273.71B
Increased by 12.01%
Revenue Next Year
332.27B
from 306.59B
Increased by 8.37%
EPS This Year
469.88
from 106.65
Increased by 340.60%
EPS Next Year
470.19
from 469.88
Increased by 0.07%
Financial currency is JPY.